Advertisement

Topics

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

14:59 EDT 29 Jun 2017 | SCRIP

No additional hiring is expected as US agency announces formal plan to return orphan review times to the original 90-day...

      

Related Stories

 

Original Article: FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

NEXT ARTICLE

More From BioPortfolio on "FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff"

Advertisement
Quick Search
Advertisement
Advertisement